Filing Details

Accession Number:
0001179110-17-008661
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-06-06 16:20:21
Reporting Period:
2017-06-02
Filing Date:
2017-06-06
Accepted Time:
2017-06-06 16:20:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1651308 Beigene Ltd. BGNE Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1662982 Xiaodong Wang C/O Mourant Ozannes Corporate Services
94 Solaris Avenue
Camana Bay E9 KY1-1108
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
American Depositary Shares Disposition 2017-06-02 5,539 $40.00 55,000 No 4 S Direct
Ordinary Shares Disposition 2017-05-11 19,682 $0.00 12,505,711 No 4 G Direct
Ordinary Shares Acquisiton 2017-05-11 9,841 $0.00 224,372 No 4 G Indirect See Footnote 5
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 G Direct
No 4 G Indirect See Footnote 5
Footnotes
  1. Each American Depositary Share represents 13 Ordinary Shares.
  2. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  3. This transaction involved a gift of securities by the Reporting Person to his children, one of whom shares Reporting Person's household. The Reporting Person disclaims beneficial ownership of the shares held by his minor child.
  4. This transaction involved a gift of securities by the Reporting Person to his minor child. The Reporting Person disclaims beneficial ownership of the shares held by his minor child.
  5. These securities are held in a UTMA account for Reporting Person's minor child, for which Reporting Person disclaims beneficial ownership.